21 | | || 15:15 |||| //Coffee break// || |
22 | | || 15:30-16:15 |||| **Radiobiology programme** || |
23 | | || 15:30 || Radiobiology overview || J. Parsons (Liverpool)|| |
24 | | || 15:40 || Generation of clinical minibeams using magnetic focussing || T. Schneider (Institut Curie)|| |
25 | | || 16:00 || The Christie Proton Research Beamline and radiobiology end-station || M.Merchant (Manchester)|| |
26 | | || 16:20-16:30 |||| //Coffee break// || |
27 | | || 16:30-18:00 |||| **Imaging, instrumentation, and dosimetry** || |
28 | | || 16:30 || [raw-attachment:xx-2020-06-24-TBD.pptx Towards a novel proton radiotherapy test bed at the University of Birmingham] || T. Price (Birmingham)|| |
29 | | || 16:45 || [raw-attachment:xx-2020-06-24-TBD.pptx Development of instrumentation for dosimetry of spatially fractionated beams] || S. Flynn (Birmingham)|| |
30 | | || 17:00 || [raw-attachment:xx-2020-06-24-TBD.pptx Status of super-thin beam monitors] || A. Howard (Imperial)|| |
31 | | || 17:15 || [raw-attachment:xx-2020-06-24-TBD.pptx Progress and next steps] || J. Matheson (STFC, RAL)|| |
32 | | || 17:30 || [raw-attachment:xx-2020-06-24-TBD.pptx Imaging and AI/ML Opportunities] || R. McLauchlan (Charing Cross Hospital)|| |
33 | | || 17:45 || Closing Discussions || All|| |
| 21 | || //15:40// |||| //Coffee break// || |
| 22 | || 15:40-16:15 |||| **Radiobiology programme** || |
| 23 | || 15:40 || Radiobiology overview || J. Parsons (Liverpool)|| |
| 24 | || 15:50 || Generation of clinical minibeams using magnetic focussing || T. Schneider (Institut Curie)|| |
| 25 | || 16:10 || The Christie Proton Research Beamline and radiobiology end-station || M.Merchant (Manchester)|| |
| 26 | || //16:30// |||| //Coffee break// || |
| 27 | || **16:40-18:00** |||| **Imaging, instrumentation, and dosimetry** || |
| 28 | || 16:40 || [raw-attachment:xx-2020-06-24-TBD.pptx Towards a novel proton radiotherapy test bed at the University of Birmingham] || T. Price (Birmingham)|| |
| 29 | || 16:55 || [raw-attachment:xx-2020-06-24-TBD.pptx Development of instrumentation for dosimetry of spatially fractionated beams] || S. Flynn (Birmingham)|| |
| 30 | || 17:10 || [raw-attachment:xx-2020-06-24-TBD.pptx Status of super-thin beam monitors] || A. Howard (Imperial)|| |
| 31 | || 17:25 || [raw-attachment:xx-2020-06-24-TBD.pptx Progress and next steps] || J. Matheson (STFC, RAL)|| |
| 32 | || 17:40 || [raw-attachment:xx-2020-06-24-TBD.pptx Imaging and AI/ML Opportunities] || R. McLauchlan (Charing Cross Hospital)|| |
| 33 | || 17:55 || Closing Discussions || All|| |